35 results
8-K
EX-99.1
EDIT
Editas Medicine, Inc.
8 May 24
Editas Medicine Announces First Quarter 2024 Results and Business Updates
7:08am
at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting on May 9 and 10. Presentations include:
oOral presentation of in vivo pre … .
Upcoming Events
Editas Medicine plans to participate in the following scientific and medical conference:
American Society of Gene and Cell Therapy
8-K
EX-99.1
EDIT
Editas Medicine, Inc.
28 Feb 24
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
7:06am
from 11 patients in the RUBY trial in a Company-sponsored webinar and in a poster at the American Society of Hematology (ASH) Annual Meeting.
Reni
8-K
EDIT
Editas Medicine, Inc.
11 Dec 23
Regulation FD Disclosure
4:23pm
release titled “Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology
8-K
EX-99.1
EDIT
Editas Medicine, Inc.
11 Dec 23
Regulation FD Disclosure
4:23pm
Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual … - sponsored webinar. The data will also be presented in a poster presentation at the American Society of Hematology (ASH) Annual Meeting in San Diego, CA
8-K
EX-99.1
kgp3ovggiusdd
3 Nov 23
Editas Medicine Announces Third Quarter 2023 Results and Business Updates
7:06am
8-K
EX-99.1
xtygx1
2 Nov 22
Editas Medicine Announces Third Quarter 2022 Results and Business Updates
6:49am
8-K
EX-99.1
p2n5m7pw
4 May 22
Editas Medicine Announces First Quarter 2022 Results and Business Updates
7:00am
8-K
EX-99.1
g3qheu8z7
8 Nov 21
Editas Medicine Announces Third Quarter 2021 Results and Business Updates
7:16am
8-K
EX-99.1
y2v2a7 aklct8zou0s
4 Aug 21
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
7:16am
8-K
EX-99.1
4c66h
5 May 21
Editas Medicine Announces First Quarter 2021 Results and Update
7:10am
8-K
EX-99.1
11pg04 j4ogzm
25 Feb 21
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
7:53am
424B5
q8jq3fjy
21 Jan 21
Prospectus supplement for primary offering
4:42pm
424B5
cj5huvarg5lsi8c p4q
19 Jan 21
Prospectus supplement for primary offering
4:33pm
8-K
EX-99.1
g3zuu
5 Nov 20
Editas Medicine Announces Third Quarter 2020 Results and Update
4:17pm